Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

ACI's 2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Community

Offices

Careers

Stay Connected

Ching-Lee Fukuda will be speaking on courtroom challenges, unexpected twists, and the lessons learned when litigation does not go...

<h3>Sorry, we weren’t able to find the terms you entered.</h3>Please try a different term or keyword.

People

Capabilities

Resources

Not Found Cards

Ching-Lee Fukuda will be speaking on courtroom challenges, unexpected twists, and the lessons learned when litigation does not go according to plan. Drawing on memorable experiences from the courtroom, the session will explore how difficult moments can sharpen litigation strategy and ultimately make lawyers better advocates.ACI’s Forum on Pharma and Biotech Patent Litigation USA & Canada brings together leading in-house and law firm counsel for a three-day program focused on the latest challenges, developments, and strategies shaping life sciences patent litigation across North America and beyond.To register and for more information, visit the <a href="https://www.americanconference.com/pharma-biotech-patent-litigation-usa/" target="_blank">website</a>.<hr>

Ching-Lee Fukuda shares courtroom lessons at ACI’s Pharma & Biotech Forum.

Sign Up

Ching-Lee Fukuda is a nationally recognized IP trial lawyer and Co-Chair of Morrison Foerster’s Life Sciences IP Litigation Group. Based in New York, she has nearly three decades of experience handling high-stakes patent and trade secret litigation. She represents clients in complex IP disputes before federal district courts, the International Trade Commission, PTAB, the Federal Circuit, and various arbitration tribunals.Ching-Lee’s practice focuses on cutting-edge technologies in medical devices and medtech, software, electronics, and chemicals. She has secured significant trial and appellate victories, including high-value jury verdicts and precedent-setting Federal Circuit decisions:<ul><li>Ching-Lee led a damages trial team for Bayer that secured a jury award of $155 million, which ranks among the top 10 largest patent verdicts in Delaware.</li><li>She successfully defended Nevro in a six-year litigation saga against Boston Scientific’s assertion of 20 patents and more than 60 trade secrets, with Boston Scientific ultimately paying Nevro $85 million.</li><li>She led an appellate team for CardioNet that obtained a rare Federal Circuit precedential opinion reversing the district court to uphold the patent eligibility of a software patent directed to cardiac monitoring technology.</li></ul>Ching-Lee has also led IP arbitration teams and has handled more than 100 PTAB proceedings, including inter partes reviews (IPRs) and post-grant reviews (PGRs), representing both patent owners and challengers.In addition to her litigation practice, Ching-Lee has been a member of Law360’s Intellectual Property Editorial Advisory Board, a member of ACI’s Advisory Board for Women Leaders in IP Law, and Co-Chair of the Intellectual Property Committee for the National Asian Pacific American Bar Association. In 2023, Ching-Lee became a founding member of Lead Counsel Summit, a non-profit organization that trains and supports IP litigators who are on the cusp of serving as lead counsel, to help them master the courtroom, clients, and team skills needed to move from second-chair to first-chair roles. Since 2022, she has been the author of the treatise, Winning the Patent Damages Case, published by Matthew Bender (LexisNexis).Clients highlight Ching-Lee’s formidable courtroom presence and sharp analytical approach, emphasizing her ability to deliver successful outcomes in particularly challenging matters. She has received a range of industry honors, including the following:<ul><li>Ranked by Chambers USA for IP: Patent in New York and Life Sciences: IP/Patent Litigation Nationwide, and by Chambers Global for Life Sciences IP/Patent Litigation</li><li>Named “Patent Lawyer of the Year” by Women in Business Law Americas in 2024.</li><li>Four times shortlisted by Managing IP for “Litigator of the Year – New York” (2021, 2023, 2025, 2026).</li><li>Recognized by LMG Life Sciences as “Post-Grant Proceedings Attorney of the Year” for two consecutive years (2020-2021).</li><li>Earned four “Impact Case of the Year” distinctions from LMG Life Sciences and inclusion in the National Law Journal Verdicts Hall of Fame (2021) and Top 10 Commercial Litigation Verdicts in the United States (2019).</li></ul>Ching-Lee earned her J.D. from Fordham University School of Law and her B.S.E., with honors, in mechanical and aerospace engineering, from Princeton University.

ACI's 2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada

14 Oct 2026 10:15 AM - 5:00 PM PDT